Tapewire

Nasdaq · USD

DNLI

Denali Therapeutics Inc.

Export transactions ↓
Tapewire entity
1735
SEC CIK
0001714899
Parsed reports
436

Last 12 months

Inside the activity.

0 purchase rows · 7 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202500
Dec 202500
Jan 202602
Feb 202600
Mar 202600
Apr 202600
May 202600
Jun 202600
Jul 202600
Aug 202601
Sep 202604
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
June 02, 2022 Filed Jun 7, 2022 00:08 UTC GrantCommon Stock 5,986 $0.00 $0.00
Disclosure

SEC source: 0001714899-22-000093 · wf-form4_165456048293686.xml · nonDerivative · entry 1

Cook Jennifer E. · CIK 0001754371 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 11,313

F1 · shares: Each share is represented by a Restricted Stock Unit ("RSU") and a contingent right to receive one share of common stock of the Issuer. 100% of the RSUs shall vest upon the earlier of (i) the one year anniversary of the grant date or (ii) the day preceding the Issuer's next annual meeting of stockholders occurring after the grant date.

F2 · balance_after: Includes 5,986 unvested restricted stock units.

Read SEC document
June 02, 2022 Filed Jun 7, 2022 00:07 UTC GrantStock Option (right to buy) · Derivative 17,959 $0.00 Strike: $24.27 $0.00
Disclosure

SEC source: 0001714899-22-000092 · wf-form4_165456046364331.xml · derivative · entry 2

FLATLEY JAY T · CIK 0001189130 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 17,959

Underlying: Common Stock · 17,959 shares

Expires 2032-06-02

F5 · derivative.exercise_date: 100% of the shares subject to the option shall vest upon the earlier of (i) the one year anniversary of the grant date or (ii) the day preceding the Issuer's next annual meeting of stockholders occurring after the grant date.

Read SEC document
June 02, 2022 Filed Jun 7, 2022 00:07 UTC GrantCommon Stock 5,986 $0.00 $0.00
Disclosure

SEC source: 0001714899-22-000092 · wf-form4_165456046364331.xml · nonDerivative · entry 1

FLATLEY JAY T · CIK 0001189130 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · See footnote

Disclosed balance after: 336,313

F1 · shares: Each share is represented by a Restricted Stock Unit ("RSU") and a contingent right to receive one share of common stock of the Issuer. 100% of the RSUs shall vest upon the earlier of (i) the one year anniversary of the grant date or (ii) the day preceding the Issuer's next annual meeting of stockholders occurring after the grant date.

F2 · shares: Shares will be issued directly to The Flatley Family Trust.

F3 · balance_after: Includes 5,986 unvested restricted stock units.

F4 · ownership.nature: The shares are held of record by The Flatley Family Trust, for which the Reporting Person serves as a trustee.

Read SEC document
June 02, 2022 Filed Jun 7, 2022 00:07 UTC GrantStock Option (right to buy) · Derivative 17,959 $0.00 Strike: $24.27 $0.00
Disclosure

SEC source: 0001714899-22-000091 · wf-form4_165456044113456.xml · derivative · entry 2

Thornberry Nancy · CIK 0001797826 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 17,959

Underlying: Common Stock · 17,959 shares

Expires 2032-06-02

F3 · derivative.exercise_date: 100% of the shares subject to the option shall vest upon the earlier of (i) the one year anniversary of the grant date or (ii) the day preceding the Issuer's next annual meeting of stockholders occurring after the grant date.

Read SEC document
June 02, 2022 Filed Jun 7, 2022 00:07 UTC GrantCommon Stock 5,986 $0.00 $0.00
Disclosure

SEC source: 0001714899-22-000091 · wf-form4_165456044113456.xml · nonDerivative · entry 1

Thornberry Nancy · CIK 0001797826 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 8,497

F1 · shares: Each share is represented by a Restricted Stock Unit ("RSU") and a contingent right to receive one share of common stock of the Issuer. 100% of the RSUs shall vest upon the earlier of (i) the one year anniversary of the grant date or (ii) the day preceding the Issuer's next annual meeting of stockholders occurring after the grant date.

F2 · balance_after: Includes 7,870 unvested restricted stock units.

Read SEC document
March 23, 2022 Filed Mar 25, 2022 21:57 UTC SaleCommon Stock 11,598 $34.14 $395,955.72
Disclosure

SEC source: 0001714899-22-000061 · wf-form4_164824543669895.xml · nonDerivative · entry 2

Tessier-Lavigne Marc · CIK 0001437435 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,024,370

F3 · price: The sale price reported in column 4 of Table I represents the weighted average sale price of the shares ranging from $33.76 to $34.69 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price.

F2 · balance_after: Includes 2,074 restricted stock units.

Read SEC document
March 23, 2022 Filed Mar 25, 2022 21:57 UTC SaleCommon Stock 8,402 $33.40 $280,626.80
Disclosure

SEC source: 0001714899-22-000061 · wf-form4_164824543669895.xml · nonDerivative · entry 1

Tessier-Lavigne Marc · CIK 0001437435 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,035,968

F1 · price: The sale price reported in column 4 of Table I represents the weighted average sale price of the shares ranging from $32.76 to $33.75 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price.

F2 · balance_after: Includes 2,074 restricted stock units.

Read SEC document
March 23, 2022 Filed Jun 28, 2022 19:07 UTC Amendment SaleCommon Stock 11,598 $34.14 $395,955.72
Disclosure

SEC source: 0001714899-22-000101 · wf-form4a_165644324155351.xml · nonDerivative · entry 2

Tessier-Lavigne Marc · CIK 0001437435 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,024,370

F1 · date: For this amended Form 4 filing the only change is to add the signature.

F4 · price: The sale price reported in column 4 of Table I represents the weighted average sale price of the shares ranging from $33.76 to $34.69 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price.

F3 · balance_after: Includes 2,074 restricted stock units.

Read SEC document
March 23, 2022 Filed Jun 28, 2022 19:07 UTC Amendment SaleCommon Stock 8,402 $33.40 $280,626.80
Disclosure

SEC source: 0001714899-22-000101 · wf-form4a_165644324155351.xml · nonDerivative · entry 1

Tessier-Lavigne Marc · CIK 0001437435 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,035,968

F1 · date: For this amended Form 4 filing the only change is to add the signature.

F2 · price: The sale price reported in column 4 of Table I represents the weighted average sale price of the shares ranging from $32.76 to $33.75 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price.

F3 · balance_after: Includes 2,074 restricted stock units.

Read SEC document
February 11, 2022 Filed Feb 15, 2022 23:58 UTC
Watts Ryan J.Director · President and CEO
SaleCommon Stock 9,491 $34.72 $329,527.52
Disclosure

SEC source: 0001714899-22-000042 · wf-form4_164496949316138.xml · nonDerivative · entry 1

Watts Ryan J. · CIK 0001724310 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Indirect · See footnote

Disclosed balance after: 2,129,648

F1 · kind: Shares sold to satisfy the tax obligations by the reporting person in connection with the settlement of previously vested restricted stock units.

F2 · price: The sale price reported in column 4 of Table I represents the weighted average sale price of the shares ranging from $34.50 to $35.17 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price.

F3 · balance_after: Reflects the issuance of shares to the Watts Family 2015 Trust in connection with the vesting of 19,697 restricted stock units held by the Reporting Person.

F4 · ownership.nature: The shares are held of record by the Watts Family 2015 Trust dated July 7, 2015, for which the Reporting Person serves as trustee.

Read SEC document
February 11, 2022 Filed Feb 15, 2022 23:55 UTC
Schuth Alexander O.COO and Secretary
SaleCommon Stock 2,803 $34.68 $97,208.04
Disclosure

SEC source: 0001714899-22-000040 · wf-form4_164496930840504.xml · nonDerivative · entry 1

Schuth Alexander O. · CIK 0001724311 · COO and Secretary

10b5-1 filing: Not disclosed

Ownership: Indirect · See footnote

Disclosed balance after: 465,047

F1 · kind: Shares sold to satisfy the tax obligations by the reporting person in connection with the settlement of previously vested restricted stock units.

F2 · price: The sale price reported in column 4 of Table I represents the weighted average sale price of the shares ranging from $34.42 to $35.11 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price.

F3 · balance_after: Reflects the issuance of shares to the Schuth Family 2017 Trust in connection with the vesting of 7,286 restricted stock units held by the Reporting Person.

F4 · ownership.nature: The shares are held of record by The Schuth Family Trust U/A DTD 06/05/2017, for which the Reporting Person serves as trustee.

Read SEC document
February 11, 2022 Filed Feb 15, 2022 23:53 UTC
Ho CaroleChief Medical Officer
SaleCommon Stock 2,918 $34.71 $101,283.78
Disclosure

SEC source: 0001714899-22-000039 · wf-form4_164496920633802.xml · nonDerivative · entry 1

Ho Carole · CIK 0001724605 · Chief Medical Officer

10b5-1 filing: Not disclosed

Ownership: Indirect · See footnote

Disclosed balance after: 170,663

F1 · kind: Shares sold to satisfy the tax obligations by the reporting person in connection with the settlement of previously vested restricted stock units.

F2 · price: The sale price reported in column 4 of Table I represents the weighted average sale price of the shares ranging from $34.44 to $35.13 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price.

F3 · balance_after: Reflects the issuance of shares to the Rohatgi-Ho Family 2009 Revocable Trust in connection with the vesting of 7,469 restricted stock units held by the Reporting Person.

F4 · ownership.nature: The shares are held of record by the Rohatgi-Ho Family 2009 Revocable Trust, for which Reporting Person serves as trustee.

Read SEC document
February 11, 2022 Filed Feb 15, 2022 23:56 UTC
Krognes Steve E.CFO and Treasurer
SaleCommon Stock 2,560 $34.69 $88,806.40
Disclosure

SEC source: 0001714899-22-000041 · wf-form4_164496940391476.xml · nonDerivative · entry 1

Krognes Steve E. · CIK 0001666236 · CFO and Treasurer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 120,221

F1 · kind: Shares sold to satisfy the tax obligations by the reporting person in connection with the settlement of previously vested restricted stock units.

F2 · price: The sale price reported in column 4 of Table I represents the weighted average sale price of the shares ranging from $34.50 to $35.07 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price.

F3 · balance_after: Includes 87,322 restricted stock units.

Read SEC document
February 10, 2022 Filed Feb 11, 2022 22:19 UTC
Watts Ryan J.Director · President and CEO
Exercise / conversionStock Option (right to buy) · Derivative 6,118 $0.00 Strike: $9.60 $0.00
Disclosure

SEC source: 0001714899-22-000035 · wf-form4_164461792855991.xml · derivative · entry 5

Watts Ryan J. · CIK 0001724310 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 6,118 shares

Expires 2027-08-21

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F6 · derivative.exercise_date: The shares subject to the option were fully vested and exercisable.

Read SEC document
February 10, 2022 Filed Feb 11, 2022 22:19 UTC
Watts Ryan J.Director · President and CEO
Exercise / conversionStock Option (right to buy) · Derivative 64,631 $0.00 Strike: $5.28 $0.00
Disclosure

SEC source: 0001714899-22-000035 · wf-form4_164461792855991.xml · derivative · entry 4

Watts Ryan J. · CIK 0001724310 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 64,631 shares

Expires 2027-03-07

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F6 · derivative.exercise_date: The shares subject to the option were fully vested and exercisable.

Read SEC document
February 10, 2022 Filed Feb 11, 2022 22:19 UTC
Watts Ryan J.Director · President and CEO
Exercise / conversionCommon Stock 6,118 $9.60 $58,732.80
Disclosure

SEC source: 0001714899-22-000035 · wf-form4_164461792855991.xml · nonDerivative · entry 3

Watts Ryan J. · CIK 0001724310 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 260,640

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · balance_after: Reflects the issuance of shares to the Watts Family 2015 Trust in connection with the vesting of 8800 restricted stock units held by the Reporting Person.

F5 · balance_after: Includes 189,891 restricted stock units.

Read SEC document
February 10, 2022 Filed Feb 11, 2022 22:19 UTC
Watts Ryan J.Director · President and CEO
Exercise / conversionCommon Stock 64,631 $5.28 $341,251.68
Disclosure

SEC source: 0001714899-22-000035 · wf-form4_164461792855991.xml · nonDerivative · entry 2

Watts Ryan J. · CIK 0001724310 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 254,522

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
February 09, 2022 Filed Feb 11, 2022 22:19 UTC
Watts Ryan J.Director · President and CEO
SaleCommon Stock 2,719 $37.55 $102,103.62
Disclosure

SEC source: 0001714899-22-000035 · wf-form4_164461792855991.xml · nonDerivative · entry 1

Watts Ryan J. · CIK 0001724310 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Indirect · See footnote

Disclosed balance after: 2,119,442

F1 · kind: Shares sold to satisfy the tax obligations by the reporting person in connection with the settlement of previously vested restricted stock units.

F2 · price: The sale price reported in column 4 of Table I represents the weighted average sale price of the shares ranging from $37.51 to $37.745 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price.

F3 · balance_after: Reflects the issuance of shares to the Watts Family 2015 Trust in connection with the vesting of 8800 restricted stock units held by the Reporting Person.

F4 · ownership.nature: The shares are held of record by the Watts Family 2015 Trust dated July 7, 2015, for which the Reporting Person serves as trustee.

Read SEC document
February 09, 2022 Filed Feb 11, 2022 22:18 UTC
Schuth Alexander O.COO and Secretary
SaleCommon Stock 1,423 $37.10 $52,799.70
Disclosure

SEC source: 0001714899-22-000034 · wf-form4_164461787567236.xml · nonDerivative · entry 1

Schuth Alexander O. · CIK 0001724311 · COO and Secretary

10b5-1 filing: Not disclosed

Ownership: Indirect · See footnote

Disclosed balance after: 460,564

F1 · kind: Shares sold to satisfy the tax obligations by the reporting person in connection with the settlement of previously vested restricted stock units.

F2 · price: The sale price reported in column 4 of Table I represents the weighted average sale price of the shares ranging from $36.71 to $37.40 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price.

F3 · balance_after: Reflects the issuance of shares to the Schuth Family 2017 Trust in connection with the vesting of 4250 restricted stock units held by the Reporting Person.

F4 · ownership.nature: The shares are held of record by The Schuth Family Trust U/A DTD 06/05/2017, for which the Reporting Person serves as trustee.

Read SEC document
February 09, 2022 Filed Feb 11, 2022 22:20 UTC
Krognes Steve E.CFO and Treasurer
SaleCommon Stock 1,296 $37.09 $48,072.66
Disclosure

SEC source: 0001714899-22-000036 · wf-form4_164461802552345.xml · nonDerivative · entry 1

Krognes Steve E. · CIK 0001666236 · CFO and Treasurer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 122,781

F1 · kind: Shares sold to satisfy the tax obligations by the reporting person in connection with the settlement of previously vested restricted stock units.

F2 · price: The sale price reported in column 4 of Table I represents the weighted average sale price of the shares ranging from $36.75 to $37.37 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price.

F3 · balance_after: Includes 94608 restricted stock units.

Read SEC document
February 09, 2022 Filed Feb 11, 2022 22:16 UTC
Ho CaroleChief Medical Officer
SaleCommon Stock 1,423 $37.10 $52,791.45
Disclosure

SEC source: 0001714899-22-000033 · wf-form4_164461775653814.xml · nonDerivative · entry 1

Ho Carole · CIK 0001724605 · Chief Medical Officer

10b5-1 filing: Not disclosed

Ownership: Indirect · See footnote

Disclosed balance after: 166,112

F1 · kind: Shares sold to satisfy the tax obligations by the reporting person in connection with the settlement of previously vested restricted stock units.

F2 · price: The sale price reported in column 4 of Table I represents the weighted average sale price of the shares ranging from $36.71 to $37.40 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price.

F3 · balance_after: Reflects the issuance of shares to the Rohatgi-Ho Family 2009 Revocable Trust in connection with the vesting of 4250 restricted stock units held by the Reporting Person.

F4 · ownership.nature: The shares are held of record by the Rohatgi-Ho Family 2009 Revocable Trust, for which Reporting Person serves as trustee.

Read SEC document
February 03, 2022 Filed Feb 7, 2022 23:54 UTC
Harris ErikDirector
GrantStock Option (right to buy) · Derivative 20,607 $0.00 Strike: $33.74 $0.00
Disclosure

SEC source: 0001714899-22-000024 · wf-form4_164427807583736.xml · derivative · entry 2

Harris Erik · CIK 0001780113 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 20,607

Underlying: Common Stock · 20,607 shares

Expires 2032-02-03

F3 · derivative.exercise_date: 25% of the shares subject to the option shall vest on February 3, 2023, and an additional 1/48 of the shares subject to the option vest each month thereafter, subject to the Reporting Person remaining a non-employee director of the Issuer through each such date

Read SEC document
February 03, 2022 Filed Feb 7, 2022 23:54 UTC
Harris ErikDirector
GrantCommon Stock 6,869 $0.00 $0.00
Disclosure

SEC source: 0001714899-22-000024 · wf-form4_164427807583736.xml · nonDerivative · entry 1

Harris Erik · CIK 0001780113 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 6,869

F1 · security: Each restricted stock unit represents a contingent right to receive one share of common stock of the Issuer.

F2 · deemedExecutionDate: 25% of the restricted stock units shall vest on February 3, 2023 (the "Vesting Commencement Date") and an additional 25% of the restricted stock units shall vest on each annual anniversary of the Vesting Commencement Date thereafter, subject to the Reporting Person remaining a non-employee director of the Issuer through each such date.

Read SEC document
January 08, 2022 Filed Jan 12, 2022 00:54 UTC GrantCommon Stock 627 $0.00 $0.00
Disclosure

SEC source: 0001714899-22-000015 · wf-form4_164194885494715.xml · nonDerivative · entry 1

Thornberry Nancy · CIK 0001797826 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,511

F1 · balance_after: The Reporting Person has reported prior awards of restricted stock units in Table II of Form 4. This total reported in Column 5 includes 1884 previously reported restricted stock units and 627 shares acquired pursuant to vesting of restricted stock units.

Read SEC document
January 05, 2022 Filed Jan 7, 2022 23:06 UTC
Watts Ryan J.Director · President and CEO
SaleCommon Stock 5,007 $44.78 $224,213.46
Disclosure

SEC source: 0001714899-22-000008 · wf-form4_164159676820157.xml · nonDerivative · entry 1

Watts Ryan J. · CIK 0001724310 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Indirect · See footnote

Disclosed balance after: 2,113,361

F1 · kind: Shares sold to satisfy the tax obligations by the reporting person in connection with the settlement of previously vested restricted stock units.

F2 · price: The sale price reported in column 4 of Table I represents the weighted average sale price of the shares purchased ranging from $44.44 to $45.05 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price.

F3 · balance_after: Reflects the issuance of shares to the Watts Family 2015 Trust in connection with the vesting of 15000 restricted stock units held by the Reporting Person.

F4 · ownership.nature: The shares are held of record by the Watts Family 2015 Trust dated July 7, 2015, for which the Reporting Person serves as trustee.

Read SEC document
January 05, 2022 Filed Jan 7, 2022 23:05 UTC
Schuth Alexander O.COO and Secretary
SaleCommon Stock 2,846 $44.77 $127,415.42
Disclosure

SEC source: 0001714899-22-000005 · wf-form4_164159671916562.xml · nonDerivative · entry 1

Schuth Alexander O. · CIK 0001724311 · COO and Secretary

10b5-1 filing: Not disclosed

Ownership: Indirect · See footnote

Disclosed balance after: 457,737

F1 · kind: Shares sold to satisfy the tax obligations by the reporting person in connection with the settlement of previously vested restricted stock units.

F2 · price: The sale price reported in column 4 of Table I represents the weighted average sale price of the shares purchased ranging from $44.44 to $45.05 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price.

F3 · balance_after: Reflects the issuance of shares to the Schuth Family 2017 Trust in connection with the vesting of 7500 restricted stock units held by the Reporting Person.

F4 · ownership.nature: The shares are held of record by The Schuth Family Trust U/A DTD 06/05/2017, for which the Reporting Person serves as trustee.

Read SEC document
January 05, 2022 Filed Jan 7, 2022 23:06 UTC
Krognes Steve E.CFO and Treasurer
SaleCommon Stock 2,225 $44.75 $99,568.75
Disclosure

SEC source: 0001714899-22-000007 · wf-form4_164159675294746.xml · nonDerivative · entry 1

Krognes Steve E. · CIK 0001666236 · CFO and Treasurer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 124,077

F1 · kind: Shares sold to satisfy the tax obligations by the reporting person in connection with the settlement of previously vested restricted stock units.

F2 · price: The sale price reported in column 4 of Table I represents the weighted average sale price of the shares purchased ranging from $44.47 to $45.05 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price.

F3 · balance_after: Includes 98,858 restricted stock units.

Read SEC document
January 05, 2022 Filed Jan 7, 2022 23:05 UTC
Ho CaroleChief Medical Officer
SaleCommon Stock 2,845 $44.78 $127,399.10
Disclosure

SEC source: 0001714899-22-000006 · wf-form4_164159673634515.xml · nonDerivative · entry 1

Ho Carole · CIK 0001724605 · Chief Medical Officer

10b5-1 filing: Not disclosed

Ownership: Indirect · See footnote

Disclosed balance after: 163,285

F1 · kind: Shares sold to satisfy the tax obligations by the reporting person in connection with the settlement of previously vested restricted stock units.

F2 · price: The sale price reported in column 4 of Table I represents the weighted average sale price of the shares purchased ranging from $44.5101 to $45.05 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price.

F3 · balance_after: Reflects the issuance of shares to the Rohatgi-Ho Family 2009 Revocable Trust in connection with the vesting of 7500 restricted stock units held by the Reporting Person.

F4 · ownership.nature: The shares are held of record by the Rohatgi-Ho Family 2009 Revocable Trust, for which Reporting Person serves as trustee.

Read SEC document
January 03, 2022 Filed Jan 6, 2022 00:03 UTC
Watts Ryan J.Director · President and CEO
GrantStock Option (right to buy) · Derivative 186,500 $0.00 Strike: $47.27 $0.00
Disclosure

SEC source: 0001714899-22-000002 · wf-form4_164142738905570.xml · derivative · entry 3

Watts Ryan J. · CIK 0001724310 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 186,500

Underlying: Common Stock · 186,500 shares

Expires 2032-01-02

F4 · derivative.exercise_date: 25% of the shares subject to the option shall vest on January 3, 2023, and 1/48 of the shares subject to the option shall vest each month thereafter, subject to the Reporting Person remaining a service provider of the Issuer through each such date.

Read SEC document
January 03, 2022 Filed Jan 6, 2022 00:03 UTC
Watts Ryan J.Director · President and CEO
GrantCommon Stock 62,000 $0.00 $0.00
Disclosure

SEC source: 0001714899-22-000002 · wf-form4_164142738905570.xml · nonDerivative · entry 1

Watts Ryan J. · CIK 0001724310 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 213,691

F1 · shares: Each share is represented by a Restricted Stock Unit ("RSU") and a contingent right to receive one share of common stock of the Issuer. 25% of the RSUs shall vest on January 3, 2023 (the "Vesting Commencement Date") and an additional 25% of the RSUs shall vest on each annual anniversary of the Vesting Commencement Date thereafter, subject to the Reporting Person remaining a service provider of the Issuer through each such date.

F2 · balance_after: Includes 213,691 restricted stock units.

Read SEC document
January 03, 2022 Filed Jan 6, 2022 00:04 UTC
Schuth Alexander O.COO and Secretary
GrantStock Option (right to buy) · Derivative 93,000 $0.00 Strike: $47.27 $0.00
Disclosure

SEC source: 0001714899-22-000004 · wf-form4_164142742987933.xml · derivative · entry 3

Schuth Alexander O. · CIK 0001724311 · COO and Secretary

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 93,000

Underlying: Common Stock · 93,000 shares

Expires 2032-01-02

F4 · derivative.exercise_date: 25% of the shares subject to the option shall vest on January 3, 2023, and 1/48 of the shares subject to the option shall vest each month thereafter, subject to the Reporting Person remaining a service provider of the Issuer through each such date.

Read SEC document
January 03, 2022 Filed Jan 6, 2022 00:04 UTC
Schuth Alexander O.COO and Secretary
GrantCommon Stock 31,000 $0.00 $0.00
Disclosure

SEC source: 0001714899-22-000004 · wf-form4_164142742987933.xml · nonDerivative · entry 1

Schuth Alexander O. · CIK 0001724311 · COO and Secretary

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 117,454

F1 · shares: Each share is represented by a Restricted Stock Unit ("RSU") and a contingent right to receive one share of common stock of the Issuer. 25% of the RSUs shall vest on January 3, 2023 (the "Vesting Commencement Date") and an additional 25% of the RSUs shall vest on each annual anniversary of the Vesting Commencement Date thereafter, subject to the Reporting Person remaining a service provider of the Issuer through each such date.

F2 · balance_after: Includes 106,358 restricted stock units.

Read SEC document
January 03, 2022 Filed Jan 6, 2022 00:03 UTC
Ho CaroleChief Medical Officer
GrantStock Option (right to buy) · Derivative 93,000 $0.00 Strike: $47.27 $0.00
Disclosure

SEC source: 0001714899-22-000003 · wf-form4_164142741424082.xml · derivative · entry 4

Ho Carole · CIK 0001724605 · Chief Medical Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 93,000

Underlying: Common Stock · 93,000 shares

Expires 2032-01-02

F5 · derivative.exercise_date: 25% of the shares subject to the option shall vest on January 3, 2023, and 1/48 of the shares subject to the option shall vest each month thereafter, subject to the Reporting Person remaining a service provider of the Issuer through each such date.

Read SEC document
January 03, 2022 Filed Jan 6, 2022 00:03 UTC
Ho CaroleChief Medical Officer
GrantCommon Stock 31,000 $0.00 $0.00
Disclosure

SEC source: 0001714899-22-000003 · wf-form4_164142741424082.xml · nonDerivative · entry 1

Ho Carole · CIK 0001724605 · Chief Medical Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 107,316

F1 · shares: Each share is represented by a Restricted Stock Unit ("RSU") and a contingent right to receive one share of common stock of the Issuer. 25% of the RSUs shall vest on January 3, 2023 (the "Vesting Commencement Date") and an additional 25% of the RSUs shall vest on each annual anniversary of the Vesting Commencement Date thereafter, subject to the Reporting Person remaining a service provider of the Issuer through each such date.

F2 · balance_after: Includes 106,906 restricted stock units.

Read SEC document
January 03, 2022 Filed Jan 6, 2022 00:03 UTC
Krognes Steve E.CFO and Treasurer
GrantStock Option (right to buy) · Derivative 93,000 $0.00 Strike: $47.27 $0.00
Disclosure

SEC source: 0001714899-22-000001 · wf-form4_164142736337791.xml · derivative · entry 3

Krognes Steve E. · CIK 0001666236 · CFO and Treasurer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 93,000

Underlying: Common Stock · 93,000 shares

Expires 2032-01-02

F4 · derivative.exercise_date: 25% of the shares subject to the option shall vest on January 3, 2023, and 1/48 of the shares subject to the option shall vest each month thereafter, subject to the Reporting Person remaining a service provider of the Issuer through each such date.

Read SEC document
January 03, 2022 Filed Jan 6, 2022 00:03 UTC
Krognes Steve E.CFO and Treasurer
GrantCommon Stock 31,000 $0.00 $0.00
Disclosure

SEC source: 0001714899-22-000001 · wf-form4_164142736337791.xml · nonDerivative · entry 1

Krognes Steve E. · CIK 0001666236 · CFO and Treasurer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 126,302

F1 · shares: Each share is represented by a Restricted Stock Unit ("RSU") and a contingent right to receive one share of common stock of the Issuer. 25% of the RSUs shall vest on January 3, 2023 (the "Vesting Commencement Date") and an additional 25% of the restricted stock units shall vest on each annual anniversary of the Vesting Commencement Date thereafter, subject to the Reporting Person remaining a service provider of the Issuer through each such date.

F2 · balance_after: Includes 106,358 restricted stock units.

Read SEC document
December 30, 2021 Filed Dec 31, 2021 02:59 UTC SaleCommon Stock 800 $45.72 $36,576.00
Disclosure

SEC source: 0001714899-21-000117 · wf-form4_164091956763788.xml · nonDerivative · entry 16

Tessier-Lavigne Marc · CIK 0001437435 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · The Tessier-Lavigne/Hynes Irrevocable Trust 3

Disclosed balance after: 78,848

F17 · price: The sale price reported in column 4 of Table I represents the weighted average sale price of the shares purchased ranging from $45.67 to $45.80 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price.

F13 · ownership.nature: The shares are held of record by The Tessier-Lavigne/Hynes Irrevocable Trust 3, for which the Reporting Person serves as trustee.

Read SEC document
December 30, 2021 Filed Dec 31, 2021 02:59 UTC SaleCommon Stock 6,002 $45.31 $271,950.62
Disclosure

SEC source: 0001714899-21-000117 · wf-form4_164091956763788.xml · nonDerivative · entry 15

Tessier-Lavigne Marc · CIK 0001437435 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · The Tessier-Lavigne/Hynes Irrevocable Trust 3

Disclosed balance after: 79,648

F16 · price: The sale price reported in column 4 of Table I represents the weighted average sale price of the shares purchased ranging from $44.65 to $45.62 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price.

F13 · ownership.nature: The shares are held of record by The Tessier-Lavigne/Hynes Irrevocable Trust 3, for which the Reporting Person serves as trustee.

Read SEC document
December 30, 2021 Filed Dec 31, 2021 02:59 UTC SaleCommon Stock 900 $45.71 $41,139.00
Disclosure

SEC source: 0001714899-21-000117 · wf-form4_164091956763788.xml · nonDerivative · entry 11

Tessier-Lavigne Marc · CIK 0001437435 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · The Tessier-Lavigne/Hynes Irrevocable Trust 2

Disclosed balance after: 79,173

F12 · price: The sale price reported in column 4 of Table I represents the weighted average sale price of the shares purchased ranging from $45.66 to $45.77 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price.

F8 · ownership.nature: The shares are held of record by The Tessier-Lavigne/Hynes Irrevocable Trust 2, for which the Reporting Person serves as trustee.

Read SEC document
December 30, 2021 Filed Dec 31, 2021 02:59 UTC SaleCommon Stock 5,625 $45.31 $254,868.75
Disclosure

SEC source: 0001714899-21-000117 · wf-form4_164091956763788.xml · nonDerivative · entry 10

Tessier-Lavigne Marc · CIK 0001437435 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · The Tessier-Lavigne/Hynes Irrevocable Trust 2

Disclosed balance after: 80,073

F11 · price: The sale price reported in column 4 of Table I represents the weighted average sale price of the shares purchased ranging from $44.65 to $45.63 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price.

F8 · ownership.nature: The shares are held of record by The Tessier-Lavigne/Hynes Irrevocable Trust 2, for which the Reporting Person serves as trustee.

Read SEC document
December 30, 2021 Filed Dec 31, 2021 02:59 UTC SaleCommon Stock 3,377 $45.59 $153,957.43
Disclosure

SEC source: 0001714899-21-000117 · wf-form4_164091956763788.xml · nonDerivative · entry 6

Tessier-Lavigne Marc · CIK 0001437435 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · The Tessier-Lavigne/Hynes Irrevocable Trust 1

Disclosed balance after: 78,848

F7 · price: The sale price reported in column 4 of Table I represents the weighted average sale price of the shares purchased ranging from $45.42 to $45.81 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price.

F3 · ownership.nature: The shares are held of record by The Tessier-Lavigne/Hynes Irrevocable Trust 1, for which the Reporting Person serves as trustee.

Read SEC document
December 30, 2021 Filed Dec 31, 2021 02:59 UTC SaleCommon Stock 3,343 $45.13 $150,869.59
Disclosure

SEC source: 0001714899-21-000117 · wf-form4_164091956763788.xml · nonDerivative · entry 5

Tessier-Lavigne Marc · CIK 0001437435 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · The Tessier-Lavigne/Hynes Irrevocable Trust 1

Disclosed balance after: 82,225

F6 · price: The sale price reported in column 4 of Table I represents the weighted average sale price of the shares purchased ranging from $44.42 to $45.41 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price.

F3 · ownership.nature: The shares are held of record by The Tessier-Lavigne/Hynes Irrevocable Trust 1, for which the Reporting Person serves as trustee.

Read SEC document
December 29, 2021 Filed Dec 31, 2021 02:59 UTC SaleCommon Stock 10,704 $43.88 $469,691.52
Disclosure

SEC source: 0001714899-21-000117 · wf-form4_164091956763788.xml · nonDerivative · entry 14

Tessier-Lavigne Marc · CIK 0001437435 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · The Tessier-Lavigne/Hynes Irrevocable Trust 3

Disclosed balance after: 85,650

F15 · price: The sale price reported in column 4 of Table I represents the weighted average sale price of the shares purchased ranging from $43.50 to $44.09 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price.

F13 · ownership.nature: The shares are held of record by The Tessier-Lavigne/Hynes Irrevocable Trust 3, for which the Reporting Person serves as trustee.

Read SEC document
December 29, 2021 Filed Dec 31, 2021 02:59 UTC SaleCommon Stock 10,700 $43.87 $469,409.00
Disclosure

SEC source: 0001714899-21-000117 · wf-form4_164091956763788.xml · nonDerivative · entry 9

Tessier-Lavigne Marc · CIK 0001437435 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · The Tessier-Lavigne/Hynes Irrevocable Trust 2

Disclosed balance after: 85,698

F10 · price: The sale price reported in column 4 of Table I represents the weighted average sale price of the shares purchased ranging from $43.51 to $44.07 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price.

F8 · ownership.nature: The shares are held of record by The Tessier-Lavigne/Hynes Irrevocable Trust 2, for which the Reporting Person serves as trustee.

Read SEC document
December 29, 2021 Filed Dec 31, 2021 02:59 UTC SaleCommon Stock 10,700 $43.88 $469,516.00
Disclosure

SEC source: 0001714899-21-000117 · wf-form4_164091956763788.xml · nonDerivative · entry 4

Tessier-Lavigne Marc · CIK 0001437435 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · The Tessier-Lavigne/Hynes Irrevocable Trust 1

Disclosed balance after: 85,568

F5 · price: The sale price reported in column 4 of Table I represents the weighted average sale price of the shares purchased ranging from $43.50 to $44.07 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price.

F3 · ownership.nature: The shares are held of record by The Tessier-Lavigne/Hynes Irrevocable Trust 1, for which the Reporting Person serves as trustee.

Read SEC document
December 28, 2021 Filed Dec 31, 2021 02:59 UTC SaleCommon Stock 3,646 $44.37 $161,773.02
Disclosure

SEC source: 0001714899-21-000117 · wf-form4_164091956763788.xml · nonDerivative · entry 13

Tessier-Lavigne Marc · CIK 0001437435 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · The Tessier-Lavigne/Hynes Irrevocable Trust 3

Disclosed balance after: 96,354

F14 · price: The sale price reported in column 4 of Table I represents the weighted average sale price of the shares purchased ranging from $44.18 to $44.63 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price.

F13 · ownership.nature: The shares are held of record by The Tessier-Lavigne/Hynes Irrevocable Trust 3, for which the Reporting Person serves as trustee.

Read SEC document
December 28, 2021 Filed Dec 31, 2021 02:59 UTC SaleCommon Stock 3,602 $44.38 $159,856.76
Disclosure

SEC source: 0001714899-21-000117 · wf-form4_164091956763788.xml · nonDerivative · entry 8

Tessier-Lavigne Marc · CIK 0001437435 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · The Tessier-Lavigne/Hynes Irrevocable Trust 2

Disclosed balance after: 96,398

F9 · price: The sale price reported in column 4 of Table I represents the weighted average sale price of the shares purchased ranging from $44.19 to $44.64 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price.

F8 · ownership.nature: The shares are held of record by The Tessier-Lavigne/Hynes Irrevocable Trust 2, for which the Reporting Person serves as trustee.

Read SEC document
December 28, 2021 Filed Dec 31, 2021 02:59 UTC SaleCommon Stock 3,732 $44.37 $165,588.84
Disclosure

SEC source: 0001714899-21-000117 · wf-form4_164091956763788.xml · nonDerivative · entry 3

Tessier-Lavigne Marc · CIK 0001437435 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · The Tessier-Lavigne/Hynes Irrevocable Trust 1

Disclosed balance after: 96,268

F4 · price: The sale price reported in column 4 of Table I represents the weighted average sale price of the shares purchased ranging from $44.19 to $44.74 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price.

F3 · ownership.nature: The shares are held of record by The Tessier-Lavigne/Hynes Irrevocable Trust 1, for which the Reporting Person serves as trustee.

Read SEC document
December 13, 2021 Filed Feb 18, 2022 01:25 UTC GiftCommon Stock 200,000 $0.00 $0.00
Disclosure

SEC source: 0001714899-22-000043 · wf-form5_164514750112269.xml · nonDerivative · entry 1

Tessier-Lavigne Marc · CIK 0001437435 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,044,370

F1 · price: This transaction involved a gift of securities by the Reporting Person. Disposition price is not applicable as this transaction was a bona fide gift.

F2 · balance_after: Includes 2,074 restricted stock units.

Read SEC document
December 06, 2021 Filed Dec 8, 2021 22:35 UTC
Schuth Alexander O.COO and Secretary
SaleCommon Stock 7,200 $42.45 $305,640.00
Disclosure

SEC source: 0001714899-21-000116 · wf-form4_163900292998153.xml · nonDerivative · entry 2

Schuth Alexander O. · CIK 0001724311 · COO and Secretary

10b5-1 filing: Not disclosed

Ownership: Indirect · See footnote

Disclosed balance after: 453,083

F1 · kind: The sales reported by the Reporting Person were effected pursuant to a Rule 10b5-1 trading plan.

F4 · price: The sale price reported in column 4 of Table I represents the weighted average sale price of the shares purchased ranging from $42.21 to $42.91 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price.

F3 · ownership.nature: The shares are held of record by The Schuth Family Trust U/A DTD 06/05/2017, for which the Reporting Person serves as trustee.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.